Gene · 1645
Papers1,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals. | J Biochem | 2024 | 38140954 | PubTator, text mining | PubMed |
| Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. | J Cell Mol Med | 2024 | 38140764 | PubTator, text mining | PubMed |
| Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-Seq. | Adv Sci (Weinh) | 2024 | 38010945 | PubTator, text mining | PubMed |
| The exploration of mitochondrial-related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer. | Cancer Rep (Hoboken) | 2024 | 37903487 | PubTator, text mining | PubMed |
| Regulation of 20α-Hydroxysteroid Dehydrogenase Expression in Term Pregnant Human Myometrium Ex Vivo. | Reprod Sci | 2024 | 37648943 | PubTator, text mining | PubMed |
| Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills. | Antioxid Redox Signal | 2024 | 37132605 | PubTator, text mining | PubMed |
| Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health. | Front Genet | 2023 | 38299096 | PubTator, text mining | PubMed |
| Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies. | Front Immunol | 2023 | 38250062 | PubTator, text mining | PubMed |
| YTHDF1 in Tumor Cell Metabolism: An Updated Review. | Molecules | 2023 | 38202722 | PubTator, text mining | PubMed |
| A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors. | Pharmaceuticals (Basel) | 2023 | 38139766 | PubTator, text mining | PubMed |
Case-Control Study of the Association between Single Nucleotide Polymorphisms of Genes Involved in Xenobiotic Detoxification and Antioxidant Protection with the Long-Term Influence of Organochlorine Pesticides on the Population of the Almaty Region. | Toxics | 2023 | 38133349 | PubTator, text mining | PubMed |
| AKR1C1 and hormone metabolism in lipedema pathogenesis: a computational biology approach. | Eur Rev Med Pharmacol Sci | 2023 | 38112954 | PubTator, text mining | PubMed |
| Aldo-keto reductase 1C2 (AKR1C2) as the second gene associated to non-syndromic primary lipedema: investigating activating mutation or overexpression as causative factors. | Eur Rev Med Pharmacol Sci | 2023 | 38112953 | PubTator, text mining | PubMed |
| Insight into the mechanism of gallstone disease by proteomic and metaproteomic characterization of human bile. | Front Microbiol | 2023 | 38111640 | PubTator, text mining | PubMed |
| Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials. | Front Oncol | 2023 | 38074675 | PubTator, text mining | PubMed |
| Human exposure to diesel exhaust induces CYP1A1 expression and AhR activation without a coordinated antioxidant response. | Part Fibre Toxicol | 2023 | 38062420 | PubTator, text mining | PubMed |
| Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer. | Acta Pharm Sin B | 2023 | 38045040 | PubTator, text mining | PubMed |
| PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. | Nat Commun | 2023 | 38030622 | PubTator, text mining | PubMed |
| The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer. | Front Genet | 2023 | 38028615 | PubTator, text mining | PubMed |
| Sedanolide Activates KEAP1-NRF2 Pathway and Ameliorates Hydrogen Peroxide-Induced Apoptotic Cell Death. | Int J Mol Sci | 2023 | 38003720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1645/papers?page=7